juveàcell is a human-tissue product based on acellular dermal matrix (hADM). The original prefilled-syringe range is intended for skin reconstruction. It is discussed when texture and density have not improved with hydration alone, taking skin thickness and responses to previous treatments into account. We explain the nature of a human-derived ECM product and its intended purpose before treatment.

How does juveàcell differ from similar treatments?

The original, V and G presentations differ. An ECM material should be distinguished from PN injectables and synthetic collagen stimulators. juveàcell V is a powder that needs separate preparation, whereas the original range comes in a prefilled syringe. Previous V or G treatment does not set the interval or aftercare for the original range.

When can I assess results from juveàcell?

For original juveàcell, follow-up relates the skin-reconstruction goal to your starting condition. We review texture, thickness and feel after swelling settles, rather than judging by immediate tightness. Even if you have had V or G before, the course of the original range is assessed on its own terms.

Does juveàcell hurt?

A prefilled syringe can still cause stinging and pressure. Thin or sensitive skin may make discomfort and swelling more noticeable. We define the injection area before discussing anaesthesia.

What is recovery and aftercare for juveàcell?

Temporary injection marks and swelling differ from lasting lumps. Avoid firm pressure and rubbing; worsening redness, warmth or tenderness needs assessment. Confirm aftercare for the original range rather than assuming V or G instructions apply.

What should I disclose before juveàcell?

We explain the human-derived ECM and intended purpose, then review any remaining HA filler or collagen stimulators. If you have had juveàcell, bring a record showing whether it was the original, V or G range. Pregnancy or breastfeeding, current medicines and any inflammation at the treatment site are also reviewed.

How do I choose a clinic for juveàcell in Gangnam, Seoul?

Look at the examination and the plan rather than the treatment name. First, what the clinic checks before deciding — at QD Clinic in Gangnam, Seoul, the first thing we look at for this treatment is “Discuss skin texture and loss of substance that hydration alone has not addressed, alongside skin thickness and previous injection history”. Second, whether it explains why it recommends that scope and method, compared with the alternatives. Third, whether it reviews your progress with you when results are expected. Our doctor goes through these three points at consultation before the treatment is decided.

Where can I get juveàcell in Seoul?

At QD Clinic in Gangnam, Seoul, South Korea. We are at 3F, 502 Gangnam-daero, Gangnam-gu, Seoul (Nonhyeon-dong, Seohee Building), a 4-minute walk from Exit 3 of Nonhyeon or Sinnonhyeon Station. Call +82-2-514-1650 or use the consultation form on this site to book a doctor’s consultation first.

juveàcell in Gangnam, Seoul, Korea | QD Clinic | Skin & Plastic Surgery Clinic

Illustrative image for understanding juveàcell

is this for me

Who it’s for

Even if none of these describes you, we will look again at the consultation.

Discuss skin texture and loss of substance that hydration alone has not addressed, alongside skin thickness and previous injection history.
The original, V and G presentations differ. An ECM material should be distinguished from PN injectables and synthetic collagen stimulators.
At QD Clinic, your goals and skin assessment guide the product, area and recovery plan.

Suitability requires an examination. Skin thickness, health and previous procedures may make a different approach more appropriate.

start with your concern

Before you pick a treatment name, start with the cause of your concern.

Even a treatment with the same name takes on a different role and scope depending on your current structure, the change you want, what you have had before and the recovery time you have.

Where you are now, and where we start
Discuss skin texture and loss of substance that hydration alone has not addressed, alongside skin thickness and previous injection history.
The change you want, the impression you keep
Suitability requires an examination. Skin thickness, health and previous procedures may make a different approach more appropriate.
How it differs from similar options
The original, V and G presentations differ. An ECM material should be distinguished from PN injectables and synthetic collagen stimulators.
Health information and recovery schedule
We explain the human-derived ECM and intended purpose, then review any remaining HA filler or collagen stimulators. If you have had juveàcell, bring a record showing whether it was the original, V or G range. Pregnancy or breastfeeding, current medicines and any inflammation at the treatment site are also reviewed.

the principle

How it works

Care that starts with the skin’s supporting matrix

juveàcell is a human-tissue product based on acellular dermal matrix (hADM). The original prefilled-syringe range is intended for skin reconstruction. The original, V and G presentations differ. An ECM material should be distinguished from PN injectables and synthetic collagen stimulators.

How it works

The product and material
juveàcell is a human-tissue product based on acellular dermal matrix (hADM). The original prefilled-syringe range is intended for skin reconstruction.
Your starting point
Discuss skin texture and loss of substance that hydration alone has not addressed, alongside skin thickness and previous injection history.
What sets it apart
The original, V and G presentations differ. An ECM material should be distinguished from PN injectables and synthetic collagen stimulators.
Assessing the change
With ECM products, the immediate appearance is distinguished from the settled tissue response. Timing depends on the area, skin and formulation.

the qd standard

The same treatment, never the same plan.

Rather than a fashionable name or a fixed package, we weigh the structure found at examination, safety, recovery and the limits within one plan.

DIAGNOSIS FIRST
Cause before name
We first separate out the tissue and the function behind your concern.
LESS, PRECISE
Only as much as needed
Rather than an excessive change, we plan the smallest scope with a clear role.
HONEST LIMIT
The limits, explained too
We explain the change you can expect, the alternatives, individual differences and the risks.

personal plan

From consultation to follow-up, planned as one flow.

Care that starts with the skin’s supporting matrix. juveàcell is a human-tissue product based on acellular dermal matrix (hADM). The original prefilled-syringe range is intended for skin reconstruction. At QD Clinic, your goals and skin assessment guide the product, area and recovery plan.

Start with the concern
Discuss skin texture and loss of substance that hydration alone has not addressed, alongside skin thickness and previous injection history.
Understand your product
The original, V and G presentations differ. An ECM material should be distinguished from PN injectables and synthetic collagen stimulators.
Plan through recovery
First confirm that the original prefilled-syringe product is planned. A previous V or G powder treatment does not establish the same schedule. Further sessions depend on the area and recovery response.

What the procedure is like

We explain the human-derived ECM and intended purpose, then review any remaining HA filler or collagen stimulators. If you have had juveàcell, bring a record showing whether it was the original, V or G range. Pregnancy or breastfeeding, current medicines and any inflammation at the treatment site are also reviewed.
The original, V and G presentations differ. An ECM material should be distinguished from PN injectables and synthetic collagen stimulators.
After appropriate comfort measures and cleansing, the doctor treats the agreed areas.
Temporary injection marks and swelling differ from lasting lumps. Avoid firm pressure and rubbing; worsening redness, warmth or tenderness needs assessment. Confirm aftercare for the original range rather than assuming V or G instructions apply.

Appointment length depends on consultation, numbing and treatment extent. Tell us your available time and important plans when booking.

Plan it with our doctors

Please read this before treatment

Temporary injection marks and swelling differ from lasting lumps. Avoid firm pressure and rubbing; worsening redness, warmth or tenderness needs assessment. Confirm aftercare for the original range rather than assuming V or G instructions apply.
Avoid strong irritation, overheating and strenuous exercise while the skin settles. Follow your instructions for washing and makeup.
Massage and pressure advice differs by product. Follow your clinician’s instructions rather than another product’s routine.

Safety & considerations

Possible reactions

Infection, persistent nodules, unevenness, inflammation or allergic reactions can occur.
Injections carry rare but serious risks including vascular injury or blockage and tissue damage.

Before treatment

Disclose pregnancy or breastfeeding, allergies, immune conditions, medicines, previous fillers and threads.
Active inflammation or infection at the site needs assessment before treatment is scheduled.

Worsening pain, pale or mottled skin, visual symptoms or breathing difficulty need urgent medical attention. Outcomes and duration vary; a specific result is not guaranteed.

what to expect

What to expect over time

A general guide to how the days and months after treatment usually unfold. Results vary by individual.

Immediately
Initial swelling and fullness are not the final result.
Early recovery
Temporary injection marks and swelling differ from lasting lumps. Avoid firm pressure and rubbing; worsening redness, warmth or tenderness needs assessment. Confirm aftercare for the original range rather than assuming V or G instructions apply.
Review
juveàcell
For original juveàcell, follow-up relates the skin-reconstruction goal to your starting condition. We review texture, thickness and feel after swelling settles, rather than judging by immediate tightness. Even if you have had V or G before, the course of the original range is assessed on its own terms.
Next steps
First confirm that the original prefilled-syringe product is planned. A previous V or G powder treatment does not establish the same schedule. Further sessions depend on the area and recovery response.

Sessions & results

First confirm that the original prefilled-syringe product is planned. A previous V or G powder treatment does not establish the same schedule. Further sessions depend on the area and recovery response.

how it compares

How it compares

The original, V and G presentations differ. An ECM material should be distinguished from PN injectables and synthetic collagen stimulators.

Comparison
	juveàcell	juveàcell V
Material	hADM / ECM	hADM / ECM
Selection	Discuss skin texture and loss of substance that hydration alone has not addressed, alongside skin thickness and previous injection history.	The consultation separates changes in skin thickness, facial volume and laxity to define a focused treatment area.
Progress	With ECM products, the immediate appearance is distinguished from the settled tissue response. Timing depends on the area, skin and formulation.	With ECM products, the immediate appearance is distinguished from the settled tissue response. Timing depends on the area, skin and formulation.

Suitability requires an examination. Skin thickness, health and previous procedures may make a different approach more appropriate.

before consultation

Before you decide, the questions people always ask

juveàcell is a human-tissue product based on acellular dermal matrix (hADM). The original prefilled-syringe range is intended for skin reconstruction. It is discussed when texture and density have not improved with hydration alone, taking skin thickness and responses to previous treatments into account. We explain the nature of a human-derived ECM product and its intended purpose before treatment.
The original, V and G presentations differ. An ECM material should be distinguished from PN injectables and synthetic collagen stimulators. juveàcell V is a powder that needs separate preparation, whereas the original range comes in a prefilled syringe. Previous V or G treatment does not set the interval or aftercare for the original range.
For original juveàcell, follow-up relates the skin-reconstruction goal to your starting condition. We review texture, thickness and feel after swelling settles, rather than judging by immediate tightness. Even if you have had V or G before, the course of the original range is assessed on its own terms.
First confirm that the original prefilled-syringe product is planned. A previous V or G powder treatment does not establish the same schedule. Further sessions depend on the area and recovery response.
A prefilled syringe can still cause stinging and pressure. Thin or sensitive skin may make discomfort and swelling more noticeable. We define the injection area before discussing anaesthesia.
Temporary injection marks and swelling differ from lasting lumps. Avoid firm pressure and rubbing; worsening redness, warmth or tenderness needs assessment. Confirm aftercare for the original range rather than assuming V or G instructions apply.
We explain the human-derived ECM and intended purpose, then review any remaining HA filler or collagen stimulators. If you have had juveàcell, bring a record showing whether it was the original, V or G range. Pregnancy or breastfeeding, current medicines and any inflammation at the treatment site are also reviewed.
Look at the examination and the plan rather than the treatment name. First, what the clinic checks before deciding — at QD Clinic in Gangnam, Seoul, the first thing we look at for this treatment is “Discuss skin texture and loss of substance that hydration alone has not addressed, alongside skin thickness and previous injection history”. Second, whether it explains why it recommends that scope and method, compared with the alternatives. Third, whether it reviews your progress with you when results are expected. Our doctor goes through these three points at consultation before the treatment is decided.
At QD Clinic in Gangnam, Seoul, South Korea. We are at 3F, 502 Gangnam-daero, Gangnam-gu, Seoul (Nonhyeon-dong, Seohee Building), a 4-minute walk from Exit 3 of Nonhyeon or Sinnonhyeon Station. Call +82-2-514-1650 or use the consultation form on this site to book a doctor’s consultation first.

juveàcell

Who it’s for

Before you pick a treatment name, start with the cause of your concern.

Where you are now, and where we start

The change you want, the impression you keep

How it differs from similar options

Health information and recovery schedule